{"Blast crisis in myelogenous leukaemia": 141.07187486164864, "Blood pressure fluctuation": 4.039463015024875, "Blood test abnormal": 7.159241529212811, "Chronic graft versus host disease": 56.00922460109511, "Chronic myeloid leukaemia": 96.63830014303232, "Chronic myeloid leukaemia recurrent": 141.01430962269995, "Complex regional pain syndrome": 36.95708549824349, "Cytogenetic analysis abnormal": 549.742567501261, "Cytopenia": 26.3497850447522, "Disease progression": 5.015185588122059, "Disease recurrence": 4.054744130744094, "Drug ineffective": 2.139267357075999, "Drug ineffective for unapproved indication": 2.9362559811529905, "Drug interaction": 2.1700677979581444, "Drug intolerance": 10.10143224235637, "Drug resistance": 45.847391323599005, "Dry skin": 2.703836652337521, "Febrile neutropenia": 3.062450639921827, "Fluid retention": 4.40757893888186, "Gastrointestinal stromal tumour": 254.6933176216501, "Gastrooesophageal reflux disease": 2.350995430253873, "Gene mutation": 62.43513421369017, "Generalised oedema": 11.544894269482665, "Haematotoxicity": 20.43860401847871, "Hepatotoxicity": 5.313876001116438, "Hunger": 11.293136601738532, "Hyperkeratosis": 16.484816635549095, "Lactose intolerance": 37.69640595005169, "Lung disorder": 3.393466268690392, "Malignant neoplasm progression": 16.363631843459284, "Metastases to liver": 27.095642301184416, "Metastases to peritoneum": 47.98240804771447, "Mouth swelling": 7.206097518885825, "Mouth ulceration": 2.9768505782505854, "Movement disorder": 2.7834182933234723, "Mucosal inflammation": 2.353545219966935, "Myelosuppression": 2.48804653982757, "Neoplasm progression": 4.893207978952876, "Neoplasm recurrence": 30.74688762020015, "Neuropathy peripheral": 2.024962921710712, "Neurotoxicity": 4.374529189614153, "Neutropenia": 2.31790110443291, "Odynophagia": 9.10890464533019, "Oedema": 3.0352545354356035, "Oral mucosal blistering": 8.27829216455867, "Palmar-plantar erythrodysaesthesia syndrome": 2.6995066922161324, "Pancytopenia": 4.10545514944025, "Pericardial effusion": 3.606468609102656, "Periorbital oedema": 9.392224739045629, "Peripheral arterial occlusive disease": 15.358808374368612, "Philadelphia chromosome positive": 161.73462635180908, "Pleural effusion": 3.394855602726898, "Recurrent cancer": 26.60677371133636, "Scleroderma": 21.810067991283336, "Second primary malignancy": 30.249790175017008, "Skin exfoliation": 2.0394623476556317, "Skin toxicity": 14.214434715056305, "Splenomegaly": 6.240926892437125, "Stomatitis": 2.3960608470048106, "Therapeutic response decreased": 7.118015100878171, "Therapy non-responder": 9.27889777408124, "Thrombocytopenia": 2.580429559702687, "Treatment failure": 8.021719892622633, "Type 2 diabetes mellitus": 3.762850403724652, "White blood cell count increased": 5.725177995073194}